Literature DB >> 6143746

Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.

G E Hogarty.   

Abstract

The need for psychosocial strategies in the treatment of schizophrenic patients after discharge is discussed in terms of relapse rates associated with maintenance neuroleptic therapy in the United States and elsewhere. The history of drug and psychosocial treatment is reviewed, and the rationale of psychosocial treatment is explained. New psychosocial approaches are explored, including the "expressed emotion" concept, the possible influence of environmental stress conditions, and the use of family therapy and social skills training to lower relapse rates.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143746

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  Modelling the treated course of schizophrenia: development of a discrete event simulation model.

Authors:  Bart Heeg; Erik Buskens; Martin Knapp; Gerda van Aalst; Pieter J T Dries; Lieuwe de Haan; Ben A van Hout
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 2.  Pharmacological treatment of patients with schizophrenia. Past and present problems and potential future therapy.

Authors:  D A Johnson
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

3.  Low dose maintenance medication for schizophrenia.

Authors:  R Manchanda; S R Hirsch
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

4.  Will the new antipsychotics improve the treatment of schizophrenia?

Authors:  T Hale
Journal:  BMJ       Date:  1993-09-25

5.  Neuroleptic medication and prescription practices with sheltered-care residents: a 12-year perspective.

Authors:  S P Segal; D Cohen; S R Marder
Journal:  Am J Public Health       Date:  1992-06       Impact factor: 9.308

6.  A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss.

Authors:  Maarten Treur; Bart Heeg; Hans-Jürgen Möller; Annette Schmeding; Ben van Hout
Journal:  BMC Health Serv Res       Date:  2009-02-18       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.